These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5037033)

  • 1. Myopathy in association with primary hyperaldosteronism.
    Sambrook MA; Heron JR; Aber GM
    J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):202-7. PubMed ID: 5037033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism.
    Abshagen U; Spörl S; Oelkers W
    Klin Wochenschr; 1979 Feb; 57(4):173-80. PubMed ID: 423483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
    Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
    Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
    [No Abstract]   [Full Text] [Related]  

  • 4. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Dtsch Med Wochenschr; 1980 May; 105(18):647-51. PubMed ID: 7371530
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebral edema and hyperaldosteronism].
    Mansuy L; Fischer G; Bret P; Ravon R
    Presse Med (1893); 1970 Dec; 78(54):2431-2. PubMed ID: 5489549
    [No Abstract]   [Full Text] [Related]  

  • 7. The occurrence of hyperaldosteronism in infants with congestive heart failure.
    Baylen BG; Johnson G; Tsang R; Srivastava L; Kaplan S
    Am J Cardiol; 1980 Feb; 45(2):305-10. PubMed ID: 6986745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokalemic paralysis due to primary hyperaldosteronism simulating Gitelman's syndrome.
    Kasifoglu T; Akalin A; Cansu DU; Korkmaz C
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):285-7. PubMed ID: 19237821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative disorders and hyperaldosteronism.
    Simopoulos AP; Delea CS; Bartter FC
    J Pediatr; 1971 Oct; 79(4):633-41. PubMed ID: 4328652
    [No Abstract]   [Full Text] [Related]  

  • 10. [An observation of Conn's syndrome. Clinical and biological study].
    Tourniaire J; Revol A; Maret G; Blanc-Brunat N
    Rev Fr Endocrinol Clin; 1968; 9(4):333-50. PubMed ID: 4302797
    [No Abstract]   [Full Text] [Related]  

  • 11. Body elemental composition, with particular reference to total and exchangeable sodium and potassium and total chlorine, in untreated and treated primary hyperaldosteronism.
    Williams ED; Boddy K; Brown JJ; Cumming AM; Davies DL; Harvey IR; Haywood JK; Lever AF; Robertson JI
    J Hypertens; 1984 Apr; 2(2):171-6. PubMed ID: 6533185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone.
    Brown JJ; Davies DL; Lever AF; Peart WS; Robertson JI
    J Endocrinol; 1965 Oct; 33(2):279-93. PubMed ID: 5845288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conn's syndrome. Study of systemic cardiovascular hemodynamics after medical treatment with spironolactone and after surgical treatment].
    Amah G; Blacher J; Girerd X; Kheder A; Ben Maiz H; Safar M
    Presse Med; 1997 Oct; 26(29):1372-7. PubMed ID: 9404344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical case of progressive hypokalemic myopathy due to Conn's syndrome].
    Kodintcev AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):149-154. PubMed ID: 36440793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modification of ionic balance by an injectable antialdosterone drug in resuscitation].
    Roquefeuil B; Nord D; Viguie E; Fischbach C
    Agressologie; 1972; 13(3):185-94. PubMed ID: 5086033
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiloride in primary hyperaldosteronism with chronic peptic ulceration.
    Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI
    Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
    Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M
    J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780
    [No Abstract]   [Full Text] [Related]  

  • 18. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and therapy of primary hyperaldosteronism in general practice].
    Bellin H; Naumann G; Schultz J
    Z Gesamte Inn Med; 1975 Jun; 30(11):391-6. PubMed ID: 1199253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.